Olet täällä



Päivitetty 22.7.2019

[1] Sane T. Aivolisäkkeen etulohko. 2010. Teoksessa: Dunkel L. Sane T, Välimäki M. Endokrinologia. Duodecim. (2. painos)
[2] Velloso C. Regulation of muscle mass by growth hormone and IGF-1. Br J Pharmacol. 2008;154(3):557-568
[3] Anderson LJ, Tamayose JM, Garcia JM. Use of growth hormone, IGF-1 and insulin for anabolic purpose: Pharmacological basis, methods of detection and adverse effects. Mol Cell Endorcinol. 2017: S0303–7207(17)30337–4
[4] Dunkel L. 2010. Kasvuhormoni – kasvurustojärjestelmä. Teoksessa: Välimäki M, Sane T, Dunkel L. Endokrinologia. Duodecim Oppiportti
[5] Karila, Karjalainen, Mäntysaari, Viitasalo, Seppälä. Anabolic androgenic steroids produce dose-dependent increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone. International Journal of Sport Medicine. 2003; 24: 337–343
[6] Neely & Rosenfeld. Use and abuse of human growth hormone. Annual Review of Medicine. 1994; 45: 407–20
[7] Segura, Gutiérrez-Gallego, Ventura, Pascual, Bosch, Such-Sanmartín, Nikolovski, Pinyot & Pichini. Growth hormone in sport: beyond Beijing 2008. Therapeutic Drug Monitoring. 2009; 31(1): 3–13
[8] Holt R, Sönksen P. Growth hormone, IGF-1 and insulin and their abuse in sport. Brit J Pharmacol. 2008; 154:542–556
[9] Hermansen K, Bengtsen M, Kjær M, Vestergaard P, Jørgensen JOL. Impact of GH administration on athletic performance in healthy young adults: A systematic review and meta-analysis of placebo-controlled trials. Growth Horm IGF Res. 2017; 34:38–44
[10] Brennan B, Kanayama G, Hudson J, Pope Jr H. Human growth hormone abuse in male weightlifters. Am J Addict. 2011;20(1):9-13
[11] Karila, Koistinen, Seppälä, Koistinen & Seppälä. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes. Clinical Endocrinology. 1998; 49: 459–463
[12] Nicholls A, Holt R. Growth hormone and insulin-like growth factor-1. Front Horm Res. 2016; 47:101–14
[13] Pope H, Wood R, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement. Endocr Rev. 2014;35(3):341-375